These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18410968)

  • 41. Treatment of recurrent Clostridium difficile infection: a systematic review.
    O'Horo JC; Jindai K; Kunzer B; Safdar N
    Infection; 2014 Feb; 42(1):43-59. PubMed ID: 23839210
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Occurrence and treatment of Clostridium difficile-associated diarrhea].
    Tvede M; Høiby N
    Ugeskr Laeger; 2006 Jun; 168(26-32):2579; author reply 2579-80. PubMed ID: 16824400
    [No Abstract]   [Full Text] [Related]  

  • 43. [Clostridium difficile infections: what is new?].
    Miftode E; Leca D; Dorneanu O
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):656-61. PubMed ID: 22046768
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Managing C. difficile-associated diarrhea.
    Bailey EM
    Am J Health Syst Pharm; 1998 Jul; 55(13):1365. PubMed ID: 9659963
    [No Abstract]   [Full Text] [Related]  

  • 45. Intravenous immunoglobulin for recurrent Clostridium difficile diarrhoea.
    Beales IL
    Gut; 2002 Sep; 51(3):456. PubMed ID: 12171976
    [No Abstract]   [Full Text] [Related]  

  • 46. Frequent emergence of resistance in Clostridium difficile during treatment of C. difficile-associated diarrhea with fusidic acid.
    Norén T; Wullt M; Akerlund T; Bäck E; Odenholt I; Burman LG
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3028-32. PubMed ID: 16940098
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Best strategies in recurrent or persistent Clostridium difficile infection.
    Cocanour CS
    Surg Infect (Larchmt); 2011 Jun; 12(3):235-9. PubMed ID: 21767157
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clostridium difficile infection in the "oldest" old: clinical outcomes in patients aged 80 and older.
    Cober ED; Malani PN
    J Am Geriatr Soc; 2009 Apr; 57(4):659-62. PubMed ID: 19392957
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rifaximin in treatment of recurrent Clostridium difficile-associated diarrhea: an uncontrolled pilot study.
    Garey KW; Jiang ZD; Bellard A; Dupont HL
    J Clin Gastroenterol; 2009 Jan; 43(1):91-3. PubMed ID: 18385603
    [No Abstract]   [Full Text] [Related]  

  • 50. Oral teicoplanin for successful treatment of severe refractory Clostridium difficile infection.
    Popovic N; Korac M; Nesic Z; Milosevic B; Urosevic A; Jevtovic D; Pelemis M; Delic D; Prostran M; Milosevic I
    J Infect Dev Ctries; 2015 Oct; 9(10):1062-7. PubMed ID: 26517480
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy.
    Jardin CG; Palmer HR; Shah DN; Le F; Beyda ND; Jiang Z; Garey KW
    J Hosp Infect; 2013 Sep; 85(1):28-32. PubMed ID: 23834988
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Probiotics for Clostridium difficile diarrhea: putting it into perspective.
    Karpa KD
    Ann Pharmacother; 2007 Jul; 41(7):1284-7. PubMed ID: 17595302
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clostridium difficile and Entamoeba histolytica infections in patients with colitis in the Philippines.
    Warren CA; Labio E; Destura R; Sevilleja JE; Jamias JD; Daez ML
    Trans R Soc Trop Med Hyg; 2012 Jul; 106(7):424-8. PubMed ID: 22657531
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clostridium difficile infection.
    Clark T; Wiselka M
    Clin Med (Lond); 2008 Oct; 8(5):544-7. PubMed ID: 18975492
    [No Abstract]   [Full Text] [Related]  

  • 55. Probiotics in relapsing and chronic diarrhea.
    Benchimol EI; Mack DR
    J Pediatr Hematol Oncol; 2004 Aug; 26(8):515-7. PubMed ID: 15284590
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Successful treatment of life-threatening, treatment resistant Clostridium difficile infection associated pseudomembranous colitis with faecal transplantation].
    Nagy GG; Várvölgyi C; Paragh G
    Orv Hetil; 2012 Dec; 153(52):2077-83. PubMed ID: 23261996
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of Clostridium difficile with enterocolitis and lactose intolerance in a foal.
    Weese JS; Parsons DA; Staempfli HR
    J Am Vet Med Assoc; 1999 Jan; 214(2):229-32, 205. PubMed ID: 9926015
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nitazoxanide is active against Clostridium difficile strains with reduced susceptibility to metronidazole.
    Freeman J; Baines SD; Todhunter SL; Huscroft GS; Wilcox MH
    J Antimicrob Chemother; 2011 Jun; 66(6):1407-8. PubMed ID: 21393199
    [No Abstract]   [Full Text] [Related]  

  • 59. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.
    Al-Nassir WN; Sethi AK; Nerandzic MM; Bobulsky GS; Jump RL; Donskey CJ
    Clin Infect Dis; 2008 Jul; 47(1):56-62. PubMed ID: 18491964
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fucidic acid use in metronidazole nonresponders with Clostridium difficile infection.
    Bektaş M; Toruner M; Cetinkaya H; Soykan I; Ozden A
    Digestion; 2007; 75(4):177-8. PubMed ID: 17687186
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.